
NASDAQHealthcareMedical - Healthcare Information Services
最新数据
US$49.74
+US$2.11 · +4.43%
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
前收盘价
US$49.74
+US$2.11 · +4.43%
盘中时间采用ET。市场数据可能有所延迟。
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
日内区间
当前US$49.74
52周区间
当前US$49.74
盘中时间采用ET。市场数据可能有所延迟。
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
日内区间
当前US$49.74
52周区间
当前US$49.74
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$46.14
下跌空间 7.24%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1.25亿0.01%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM9624.77万0.12%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB8989.62万0.05%1853亿 USD0.03%US$289.48+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR5715.01万0.08%682亿 USD0.05%US$234.43+0.22%
iShares Russell 2000 Growth ETFIWO3376.06万0.24%139.17亿 USD0.24%US$356.78+0.94%
Vanguard Russell 2000 ETFVTWO2328.4万0.13%180亿 USD0.06%US$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA1687.59万0.08%218.24亿 USD0.03%US$32.79+0.40%
Vanguard Extended Market ETFVXF1055.68万0.01%954亿 USD0.05%US$235+0.80%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
iShares Russell 2000 Growth ETFIWO
Vanguard Russell 2000 ETFVTWO
Schwab U.S. Small-Cap ETFSCHA
Vanguard Extended Market ETFVXFAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。